UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

24 Jun 2013

UCB CEO Elected Vice President of the EFPIA Board

Read More
20 Jun 2013

New data further reinforcing UCB's commitment to epilepsy to be presented at International Epilepsy Congress

Read More
14 Jun 2013

Update on share capital, securities carrying voting rights and voting rights

Read More
14 Jun 2013

Axial spondyloarthritis patients treated with certolizumab pegol reported improvements in pain, fatigue and physical function, and increased workplace and household productivity

Read More
13 Jun 2013

RAPID™-PsA study highlights burden of psoriatic arthritis and showed that patients treated with certolizumab pegol reported improvements in pain and fatigue, and increased productivity at work and within the home

Read More
13 Jun 2013

UCB announces new results from phase 2b open-label extension study evaluating the long-term effects of epratuzumab in SLE

Read More

Stay up-to-date on the latest news and information from UCB